£425.00

It has never been this cheap. We have no record of a lower price.

£425 today · cheaper than every other day in the last 3 months

Cancer Therapies Outlook in Oceana 2016-2021 Econometric Study

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 23 days · 23 data points (no recent data)

Historical
Generating forecast…
£425.00 £403.75 £412.25 £420.75 £429.25 £437.75 £446.25 03 August 2026 08 August 2026 14 August 2026 19 August 2026 25 August 2026
View at Amazon ↗

Price data last checked 68 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 23 days • 1 price levels

Days at Price
23 days 0 6 12 17 23 £425 Days at Price

Price Analysis

Most common price: £425 (23 days, 100.0%)

Price range: £425 - £425

Price levels: 1 different prices over 23 days

Description

This econometric study provides a detailed analysis of the outlook for cancer therapies within the Oceana region from 2016 to 2021. Published by ICON Group International, Inc., the report utilizes econometric models to project fundamental economic dynamics both within and across individual countries. For each reported year, the study provides estimates for latent demand, also referred to as potential industry earnings (P.I.E.), measured in millions of U.S. dollars. Readers can access specific data regarding the percent share each country holds within the region and the global market. These comparative benchmarks allow for a quick assessment of individual country performance relative to others. This professional resource is designed for those requiring data-driven insights into regional economic trends and market potential.

Key Features

Provides annual estimates for latent demand and potential industry earnings (P.I.E.) in millions of U.S. dollars.

Includes comparative benchmarks showing each country's percent share of the Oceana region and the global market.

Uses econometric models to project fundamental economic dynamics within and across different countries.

Covers the specific outlook for cancer therapies in the Oceana region for the period of 2016-2021.

Offers data published by ICON Group International, Inc. to assist in gauging country performance against others.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
21 May 2015
Listed Since
06 October 2015

Similar Products You Might Like

Cancer Therapy Outlook 2016-2021 - North America & Caribbean
99% match

Cancer Therapy Outlook 2016-2021 - North America & Caribbean

£425.00 22 Aug 2026
Cancer Therapies in Asia 2016-2021 Outlook - Econometric Study
99% match

Cancer Therapies in Asia 2016-2021 Outlook - Econometric Study

£425.00 22 Aug 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in China
98% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in China

£495.00 23 Sep 2026
The 2025-2030 World Outlook for Cancer Therapies
98% match

The 2025-2030 World Outlook for Cancer Therapies

Price unavailable
The 2023-2028 Outlook for Cancer Supportive Care Drugs in Japan
98% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in Japan

£495.00 02 Oct 2026
Hematology and Oncology Products Outlook in Oceana Book
98% match

Hematology and Oncology Products Outlook in Oceana Book

£425.00 21 Aug 2026
The 2023-2028 Outlook for Cancer Supportive Care in the United States
98% match

The 2023-2028 Outlook for Cancer Supportive Care in the United States

£520.00 22 Aug 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States
97% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States

£520.00 21 Aug 2026
NSCLC Therapeutics Outlook in Asia (2013-2018) Study
97% match

NSCLC Therapeutics Outlook in Asia (2013-2018) Study

£325.00 27 Aug 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in India
97% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in India

£515.00 21 Aug 2026
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe
97% match

The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe

£325.00 27 Sep 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in China
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in China

£495.00 01 Oct 2026
The 2023-2028 Outlook for Cancer Screenings in the United States
97% match

The 2023-2028 Outlook for Cancer Screenings in the United States

£520.00 20 Aug 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in Japan
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in Japan

£495.00 26 Sep 2026
The 2025-2030 World Outlook for Cancer Specialty Hospitals
97% match

The 2025-2030 World Outlook for Cancer Specialty Hospitals

Price unavailable
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa & the Middle East
97% match

The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa & the Middle East

£325.00 26 Sep 2026
The 2025-2030 World Outlook for Cancer Screenings
97% match

The 2025-2030 World Outlook for Cancer Screenings

Price unavailable
Hematology and Oncology Products Outlook 2016-2021 Report
97% match

Hematology and Oncology Products Outlook 2016-2021 Report

£425.00 20 Aug 2026
The 2023-2028 Outlook for Cancer Testing-Screening in India
97% match

The 2023-2028 Outlook for Cancer Testing-Screening in India

£515.00 01 Oct 2026
The 2023-2028 Outlook for Cancer Testing-Screening in the United States
97% match

The 2023-2028 Outlook for Cancer Testing-Screening in the United States

£520.00 30 Sep 2026
The 2023-2028 Outlook for Cancer Testing-Screening in Japan
97% match

The 2023-2028 Outlook for Cancer Testing-Screening in Japan

£495.00 02 Oct 2026
The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics
97% match

The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£790.00 01 Oct 2026
The 2023-2028 Outlook for Cancer Testing-Screening in China
97% match

The 2023-2028 Outlook for Cancer Testing-Screening in China

£495.00 02 Oct 2026
The 2013-2018 Outlook for Pancreatic Cancer Drugs in Oceana
97% match

The 2013-2018 Outlook for Pancreatic Cancer Drugs in Oceana

£325.00 25 Aug 2026